CWM
EXAS

Calamos Wealth Management’s Exact Sciences EXAS Stock Holding History

Calamos Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29,011
Closed -$3.61M – 312
2021
Q2 		$3.61M Buy
+29,011
New +$3.46M 0.28% 80
2015
Q4 		– Sell
-10,890
Closed -$196K – 262
2015
Q3 		$196K Buy
+10,890
New +$250K 0.05% 225

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Calamos Wealth Management's EXAS Position: Q3 2021 in Review

Calamos Wealth Management sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 29,011 shares — an estimated $3.61M sold.

Calamos Wealth Management first reported a position in EXAS in Q3 2015 and held it in 2 quarters. The position peaked at $3.61M in Q2 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Calamos Wealth Management reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Calamos Wealth Management sold 29,011 Exact Sciences shares in Q3 2021, an estimated $3.61M.
  • Calamos Wealth Management first reported a position in Exact Sciences in Q3 2015 and held it in 2 quarters.
  • Calamos Wealth Management's Exact Sciences position peaked at $3.61M in Q2 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Calamos Wealth Management's 13F filing for Q3 2021, filed 26 Oct 2021.